81. Saloura, V., et al., An open- label single -arm, phase II trial of zalutumumab, a human monoclonal anti -EGFR antibody, in patients with platinum-r efractory squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol, 2014. 73 (6): p. 1227-39.